No, metformin should NOT be taken by patients on dialysis
Metformin is contraindicated in patients on dialysis and must be stopped if dialysis is initiated. The most authoritative guidance—the 2022 KDIGO guidelines and FDA labeling—explicitly state that metformin should be discontinued when eGFR falls below 30 mL/min/1.73 m², which includes all dialysis patients 1, 2.
Why Metformin is Contraindicated on Dialysis
Risk of Lactic Acidosis
- Metformin is substantially excreted by the kidney and accumulates when kidney function is severely impaired 2
- The FDA includes a boxed warning for lactic acidosis risk in patients with kidney disease 2
- Dialysis patients have eGFR <15 mL/min/1.73 m² (or unmeasurable), far below the safety threshold of 30 mL/min/1.73 m²
Clear Guideline Recommendations
The 2022 KDIGO guidelines explicitly state 1:
- Stop metformin when eGFR <30 mL/min/1.73 m²
- Do not initiate metformin when eGFR <30 mL/min/1.73 m²
- The treatment algorithm shows metformin is NOT an option for patients on dialysis
The FDA labeling reinforces this 2:
- Metformin is contraindicated in patients with eGFR <30 mL/min/1.73 m²
- Initiation is not recommended even between 30-45 mL/min/1.73 m²
Alternative Diabetes Medications for Dialysis Patients
When patients reach dialysis, switch to 1:
- GLP-1 receptor agonists (dulaglutide can be used with eGFR >15 mL/min/1.73 m²)
- DPP-4 inhibitors
- Insulin (with careful titration to avoid hypoglycemia)
- Sulfonylureas (with caution due to hypoglycemia risk)
- Thiazolidinediones
Important Caveats About Research Studies
While small observational studies suggest metformin might be cleared by peritoneal dialysis 3, 4, these findings:
- Come from very small sample sizes (35-83 patients)
- Provide only very low-quality evidence 5
- Are not sufficient to override guideline recommendations
- Used cautious dosing (500-1000 mg daily) in highly selected patients
- A 2019 systematic review concluded the evidence is "inconclusive" and that appropriately designed trials are needed 5
Clinical Bottom Line
Stop metformin immediately when a patient starts dialysis. The risk of metformin accumulation and potentially fatal lactic acidosis outweighs any glycemic benefit, especially when multiple safer alternatives exist. While metformin is dialyzable (clearance up to 170 mL/min under good conditions) 2, 6, this does not make routine use safe—dialysis for metformin removal is a treatment for overdose/toxicity, not a strategy for ongoing therapy.
If metformin-associated lactic acidosis occurs, prompt hemodialysis is the recommended treatment to remove accumulated drug 2, 6.